News

Cognivue Names Paul W. Estes as President— Promotion of Company Veteran Reflects Neuroscience Technology Developer’s Next Evolutionary Stage

Neuroscience technology innovator Cognivue, Inc. announced today that Paul W. Estes has been promoted to president, ushering in the company’s next stage of market evolution. He will guide the executive leadership team and oversee the company’s technology roadmap planning, new product expansion, partnership relations, sales, and staffing....

Cognivue Names Dr. Ernest Fung as Vice President of Clinical and Medical Affairs

Neuroscience technology company Cognivue, Inc. has hired Ernest Fung, PsyD, ABPP, as vice president of Clinical and Medical Affairs. A distinguished clinical and forensic neuropsychologist, he brings a wealth of experience to Cognivue’s executive leadership team. Cognivue President and CEO Tom O’Neill said, “Dr. Fung’s rare blend of business and clinical experience, combined with his specialization in cognitive performance assessment and knowledge of neurodegenerative disorders as well as traumatic brain injury, will further advance Cognivue’s innovative work. We are privileged to welcome him to our veteran team...

Cognivue & DigiCARE Realized Partner to Offer Health Systems an AI-Powered Approach

ROCHESTER, N.Y. (Aug. 2, 2023)—Cognivue, Inc. and DigiCARE Realized today announced a strategic partnership to improve routine brain care across health care systems, focusing on earlier detection of Alzheimer’s disease and related dementias (ADRD). Coming on the heels of the landmark FDA approval of Leqembi, this collaboration will draw upon two transformative cognitive assessment technologies. DigiCARE Realized’s artificial...

The Kutcher Clinic Launches First-of-its-Kind Concussion Study with Cognivue®

A first-of-its-kind large-scale study conducted by the Kutcher Clinic for Sports Neurology aims to evaluate and refine how concussions are identified and treated using evidence-based diagnostic inputs. The study is funded in part by...

Cognivue Names Renowned Neuroscientist Dr. James E. Galvin as Chief Scientific Officer

ROCHESTER, NY (March 7, 2023) Renowned neuroscientist Dr. James E. Galvin has joined Cognivue as Chief Scientific Officer. He is the founding director of the Comprehensive Center for Brain Health, professor of…

Cognivue National Study Draws Remarkable 37 Percent Participation Rate of Historically Underrepresented Populations

ROCHESTER, NY (February 7, 2023) Neuroscience company Cognivue has a reported a remarkable 37 percent research participation rate of historically underserved and underrepresented populations in its national Further the Objective and Clinical…

BEYOND THE AUDIOGRAM: Whole-Brain Hearing and Listening

BEYOND THE AUDIOGRAM: Whole-Brain Hearing and Listening Difficulty hearing in noise often drives older adults to seek help, but most hearing screening tests for loudness, not clarity. Both measures are needed for…

Still Battling Turf Wars: 2022

Tech Topic | November 2022 Hearing Review Turf wars are sometimes disguised as SOP issues By Douglas L. Beck, AuD Article link After 10 years of working primarily in the operating room, I…

Cognivue Launches National Study to Further Differentiate Patented Cognitive Assessment Systems

ROCHESTER, NY (July 26, 2022) Neuroscience company Cognivue will launch a large-scale U.S. study next month to further differentiate the effectiveness of its cognitive assessment systems. The Further, Objective, Clinical, Understanding, Study…

Cognivue Recruits National Leaders for Audiology Advisory Committee

ROCHESTER, NY (June 28, 2022) Neuroscience company Cognivue has recruited 16 national leaders for its new Audiology Advisory Committee. Cognivue is an emerging leader in cognitive assessment technologies, data collection, and training…

Cognivue Names Paul W. Estes as President— Promotion of Company Veteran Reflects Neuroscience Technology Developer’s Next Evolutionary Stage

Neuroscience technology innovator Cognivue, Inc. announced today that Paul W. Estes has been promoted to president, ushering in the company’s next stage of market evolution. He will guide the executive leadership team and oversee the company’s technology roadmap planning, new product expansion, partnership relations, sales, and staffing....

Cognivue Names Dr. Ernest Fung as Vice President of Clinical and Medical Affairs

Neuroscience technology company Cognivue, Inc. has hired Ernest Fung, PsyD, ABPP, as vice president of Clinical and Medical Affairs. A distinguished clinical and forensic neuropsychologist, he brings a wealth of experience to Cognivue’s executive leadership team. Cognivue President and CEO Tom O’Neill said, “Dr. Fung’s rare blend of business and clinical experience, combined with his specialization in cognitive performance assessment and knowledge of neurodegenerative disorders as well as traumatic brain injury, will further advance Cognivue’s innovative work. We are privileged to welcome him to our veteran team...

Cognivue & DigiCARE Realized Partner to Offer Health Systems an AI-Powered Approach

ROCHESTER, N.Y. (Aug. 2, 2023)—Cognivue, Inc. and DigiCARE Realized today announced a strategic partnership to improve routine brain care across health care systems, focusing on earlier detection of Alzheimer’s disease and related dementias (ADRD). Coming on the heels of the landmark FDA approval of Leqembi, this collaboration will draw upon two transformative cognitive assessment technologies. DigiCARE Realized’s artificial...

The Kutcher Clinic Launches First-of-its-Kind Concussion Study with Cognivue®

A first-of-its-kind large-scale study conducted by the Kutcher Clinic for Sports Neurology aims to evaluate and refine how concussions are identified and treated using evidence-based diagnostic inputs. The study is funded in part by...

Cognivue Names Renowned Neuroscientist Dr. James E. Galvin as Chief Scientific Officer

ROCHESTER, NY (March 7, 2023) Renowned neuroscientist Dr. James E. Galvin has joined Cognivue as Chief Scientific Officer. He is the founding director of the Comprehensive Center for Brain Health, professor of…

Cognivue National Study Draws Remarkable 37 Percent Participation Rate of Historically Underrepresented Populations

ROCHESTER, NY (February 7, 2023) Neuroscience company Cognivue has a reported a remarkable 37 percent research participation rate of historically underserved and underrepresented populations in its national Further the Objective and Clinical…

BEYOND THE AUDIOGRAM: Whole-Brain Hearing and Listening

BEYOND THE AUDIOGRAM: Whole-Brain Hearing and Listening Difficulty hearing in noise often drives older adults to seek help, but most hearing screening tests for loudness, not clarity. Both measures are needed for…

Still Battling Turf Wars: 2022

Tech Topic | November 2022 Hearing Review Turf wars are sometimes disguised as SOP issues By Douglas L. Beck, AuD Article link After 10 years of working primarily in the operating room, I…

Cognivue Launches National Study to Further Differentiate Patented Cognitive Assessment Systems

ROCHESTER, NY (July 26, 2022) Neuroscience company Cognivue will launch a large-scale U.S. study next month to further differentiate the effectiveness of its cognitive assessment systems. The Further, Objective, Clinical, Understanding, Study…

Cognivue Recruits National Leaders for Audiology Advisory Committee

ROCHESTER, NY (June 28, 2022) Neuroscience company Cognivue has recruited 16 national leaders for its new Audiology Advisory Committee. Cognivue is an emerging leader in cognitive assessment technologies, data collection, and training…